Abcellera Biologics Inc (NASDAQ:ABCL)

BATS BZX Real-Time Price
As of 3:07pm ET
 -0.14 / -1.02%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Abcellera Biologics Inc have a median target of 32.00, with a high estimate of 43.00 and a low estimate of 14.00. The median estimate represents a +136.34% increase from the last price of 13.54.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Abcellera Biologics Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 215.40%
Growthannually 23.90%


Growthquarterly 29.44%
Growthannually 24.04%
Key to the earnings and sales forecast charts.